Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Becton Dickinson and Co    BDX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Becton Dickinson's 1st-Quarter Earnings Surge; Raises Year-View

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/05/2013 | 12:50pm CET
   By Saabira Chaudhuri 
 

Becton Dickinson & Co.'s (>> Becton, Dickinson and Co.) fiscal first-quarter earnings more than doubled as the medical device maker recorded revenue growth across all its segments, while margins also widened.

For the current year, Becton raised the bottom end of its revenue guidance, now expecting foreign currency neutral revenue growth starting at 4% versus its prior view starting at 3.5%. It now expects per-share earnings from continuing operations between $5.69 and $5.72, up from its prior view of earnings between $5.58 and $5.64.

The maker of products like surgical blades and test kits last spring struck a deal to sell the bulk of its lab-products business to Corning Inc. (>> Corning Incorporated) for $730 million in cash. Analysts who follow the company noted the sale stripped Becton Dickinson of a cash cow yet also gave it the freedom to focus on businesses with higher growth potential.

Ahead of the company's earnings announcement, analysts at Mizuho Securities downgraded Becton's ratings, noting that the company's life science research business--which makes up about 15% of sales--has been a drag on results for the past year, adding that they see no significant catalysts for the business in the near-term, as the academic market continues to be sluggish.

Still, Chief Executive Vincent A. Forlenza on Tuesday said the company is "starting to see notable results," adding that Becton is "growing revenues across our three segments, driving margin expansion and delivering a higher quality of earnings."

For the quarter ended Dec. 31, Becton Dickinson reported a profit of $625.4 million, or $3.13 a share, compared with $263 million, or $1.21 a share, a year earlier. Per-share earnings from continuing operations were $1.35 versus $1.14.

Revenue increased 3.7% to $1.9 billion. Analysts polled by Thomson Reuters most recently forecast earnings of $1.24 a share on revenue of $1.86 billion.

Gross margin widened to 52.9% from 50.8%.

Becton Dickinson's sales grew 3% in the U.S. and 4.3% internationally. The company's medical unit, its largest by revenue, reported sales rose 3.5%. The diagnostics business posted revenue growth 5%, while bioscience revenue was up 1.7%.

Shares closed Monday at $85.16 and were inactive premarket. The stock has risen 11% in the past three months.

Write to Saabira Chaudhuri at saabira.chaudhuri@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Becton, Dickinson and Co., Corning Incorporated
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BECTON DICKINSON AND CO
01/18 BECTON DICKINSON AND : BD Announces Webcast of Annual Meeting of Shareholders
01/18 BECTON DICKINSON AND : BD Announces Live Webcast of First Fiscal Quarter Earning..
01/18 BECTON DICKINSON AND : BD to Present at the 35th Annual J. P. Morgan Healthcare ..
01/18 BECTON DICKINSON AND : BD Launches Reagents to Simplify Single Cell Research; Pr..
01/17 BECTON DICKINSON AND : BD Launches Reagents to Simplify Single Cell Research
01/12 BECTON DICKINSON AND : Researchers at National Taiwan University Hospital Discus..
01/12 BECTON DICKINSON AND : What's in a name?
01/11 BECTON DICKINSON AND : Modification/Amendment - Maintenance of a Government-owne..
01/11 BECTON DICKINSON AND : BD Announces Live Webcast of First Fiscal Quarter Earning..
01/09 BECTON DICKINSON AND : BD to Present at the 35th Annual J. P. Morgan Healthcare ..
More news
Sector news : Medical Supplies
01/17DJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
01/17DJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
01/17DJWHAT'S NEWS : Business & Finance -- WSJ
01/16 ESSILOR INTL : Luxottica's merger helps Del Vecchio manage family risks
01/16DJLUXOTTICA : Another Big Splash by Italy's Eyewear King
More sector news : Medical Supplies
News from SeekingAlpha
01/17 DGI FOR THE DIY : 2016 Portfolio Review
01/12 Becton, Dickinson and Company (BDX) Presents At 35th Annual J.P. Morgan Healt..
01/11 4 Dividend-Paying Stocks That We Don't Yet Own
01/10 My Dividend Growth Portfolio - Q4 2016 Summary
01/09 Dripping For Fun And Profit
Advertisement
Financials ($)
Sales 2017 12 060 M
EBIT 2017 2 736 M
Net income 2017 1 632 M
Debt 2017 8 708 M
Yield 2017 1,66%
P/E ratio 2017 21,88
P/E ratio 2018 19,40
EV / Sales 2017 3,80x
EV / Sales 2018 3,46x
Capitalization 37 098 M
More Financials
Chart BECTON DICKINSON AND CO
Duration : Period :
Becton Dickinson and Co Technical Analysis Chart | BDX | US0758871091 | 4-Traders
Full-screen chart
Technical analysis trends BECTON DICKINSON ...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 186 $
Spread / Average Target 7,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Vincent A. Forlenza Chairman, President & Chief Executive Officer
Christopher R. Reidy EVP, Chief Financial & Administrative Officer
Ellen R. Strahlman Chief Medical Officer, EVP-Research & Development
Bertram L. Scott Independent Director
Gary A. Mecklenburg Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BECTON DICKINSON AND C..5.09%37 098
TELEFLEX INCORPORATED3.27%7 331
SHANDONG WEIGAO GROUP ..0.39%3 010
HARTALEGA HOLDINGS BER..--.--%1 686
TOP GLOVE CORPORATION ..--.--%1 455
HOGY MEDICAL CO., LTD.-6.80%958
More Results